Havana.- The Havana-based Center for Genetic Engineering and Biotechnology (CIGB) has come up with a treatment against the Hepatitis C virus that will contribute to a long-term cure of liver damage caused by the illness. The product is a combination of Alpha-2B interferon and Rivairina, both Cuban-made drugs, an AIN news agency note said. Cuban patients can now rely on an alternative treatment that increases possibilities to control the illness, Dr. Hugo Nodarse of CIGB Pharmaceutical Sciences told AIN. The combination of these two formulas allows for an increased therapeutic response in people suffering from chronic hepatitis.